Delivery Order SPE2DB20D1100-SPE2DB25FE5F6
- Not listed
- The Defense Logistics Agency awarded a $2,662.80 delivery order to AmerisourceBergen Drug Corp for ALBURX (Human) 5% Vial 500ML, a pharmaceutical product to be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This competitively awarded, firm fixed-price delivery order carries an ultimate completion date of August 14, 2025, and was issued on July 24, 2025. The award utilized no set-aside designation, reflecting AmerisourceBergen's qualification to compete in...
- The Defense Logistics Agency awarded a delivery order valued at $1,140.75 to AmerisourceBergen Drug Corp for the supply of ALBUKED-25 VIAL 100ML, with an ultimate completion date of August 21, 2025. This firm fixed-price delivery order represents a non-competitive, non-set-aside award to the pharmaceutical distributor's Corporate Office location in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a $1,368.90 firm fixed-price delivery order to AmerisourceBergen Drug Corp for pharmaceutical supplies, specifically ALBUKED-25 VIAL 100ML, with performance in Conshohocken, Pennsylvania and an ultimate completion date of September 24, 2025. This non-set-aside competitive award was issued on September 3, 2025, and represents a child delivery order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Albutein 5% vial 500ml, a pharmaceutical product commonly used in medical settings. This competitively awarded, firm fixed price delivery order has a ceiling value of $1,441.80 and an ultimate completion date of September 3, 2025. The order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was applied...
- The Defense Logistics Agency awarded a $1,650.75 firm fixed-price delivery order to AmerisourceBergen Drug Corp for ALBUKED-5 VIAL 250ML, with an ultimate completion date of August 21, 2025. This non-set-aside contract was competitively awarded and represents a child order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,007.60 firm fixed-price delivery order is for the supply of 100 ml vials of Albutein 25%, a specialty pharmaceutical product. The contract has an ultimate completion date of January 8, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,300 fixed-price delivery order is for the supply of ALBUTEIN 5% VIAL 250ML, a pharmaceutical product. The contract has an ultimate completion date of December 20, 2022. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $6,231.00 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which has an ultimate completion date of January 26, 2024, is for the procurement of ALBUKED-5 VIAL 250ML medical products. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with DLA Troop Support Medical. The...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $87,321.50 to AmerisourceBergen Drug Corp on August 25, 2025, with completion expected by August 26, 2025. This firm fixed price, non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.99 million through December 2026. The delivery order will be performed at AmerisourceBergen's...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $41,480.40 to AmerisourceBergen Drug Corp on July 29, 2025, with an ultimate completion date of July 30, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award carries no set-aside designation...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FE5F6Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,331.40 to AmerisourceBergen Drug Corp for ALBURX (Human) 5% Vial 500ML on September 8, 2025, with an ultimate completion date of September 29, 2025. This is a firm fixed-price delivery order issued under a competitive procurement with no set-aside designation. The award was placed to AmerisourceBergen Drug Corp's Corporate Office, headquartered in Conshohocken, Pennsylvania, which serves as a primary pharmaceutical distributor and healthcare solutions provider for federal medical procurement needs. This delivery order is a child contract issued under AmerisourceBergen Drug Corp's significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The parent IDC functions as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs worldwide. AmerisourceBergen Drug Corp's federal contract portfolio demonstrates extensive experience fulfilling DLA Medical Supply Chain requirements across multiple therapeutic domains, positioning the company as a critical vendor for Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 9/8/25 |